134 related articles for article (PubMed ID: 22551558)
21. Viral factors correlate with hepatitis B e antigen seroconverson in patients with chronic hepatitis B.
Liu CJ; Chen PJ; Lai MY; Lin FY; Wang T; Kao JH; Chen DS
Liver Int; 2006 Oct; 26(8):949-55. PubMed ID: 16953835
[TBL] [Abstract][Full Text] [Related]
22. Precore stop codon mutation of hepatitis B virus is associated with low breakthrough rate following long-term lamivudine therapy.
Shin JW; Chung YH; Choi MH; Kim JA; Ryu SH; Jang MK; Kim IS; Park NH; Lee HC; Lee YS; Suh DJ
J Gastroenterol Hepatol; 2005 Jun; 20(6):844-9. PubMed ID: 15946130
[TBL] [Abstract][Full Text] [Related]
23. Basal core promoter, precore region mutations of HBV and their association with e antigen, genotype, and severity of liver disease in patients with chronic hepatitis B in India.
Chauhan R; Kazim SN; Bhattacharjee J; Sakhuja P; Sarin SK
J Med Virol; 2006 Aug; 78(8):1047-54. PubMed ID: 16789012
[TBL] [Abstract][Full Text] [Related]
24. Hepatitis B e antigen-negative chronic hepatitis B in Hong Kong.
Chan HL; Leung NW; Hussain M; Wong ML; Lok AS
Hepatology; 2000 Mar; 31(3):763-8. PubMed ID: 10706570
[TBL] [Abstract][Full Text] [Related]
25. Role of hepatitis B viral load and basal core promoter mutation in hepatocellular carcinoma in hepatitis B carriers.
Liu CJ; Chen BF; Chen PJ; Lai MY; Huang WL; Kao JH; Chen DS
J Infect Dis; 2006 May; 193(9):1258-65. PubMed ID: 16586363
[TBL] [Abstract][Full Text] [Related]
26. Two distinct types of hepatitis B virus core promoter variants in Yemeni blood donors.
Sallam TA; Tong CY
J Med Virol; 2002 Nov; 68(3):328-34. PubMed ID: 12226818
[TBL] [Abstract][Full Text] [Related]
27. [Core promoter mutations of HBV isolated from patients with chronic hepatitis B in Guangxi].
Fang ZL; Zhuang H; Ge XM; Yang JY; Wang XY; Gong J; Li RC; Ling R; Harrison TJ
Zhonghua Gan Zang Bing Za Zhi; 2003 Aug; 11(8):477-8. PubMed ID: 12939180
[TBL] [Abstract][Full Text] [Related]
28. Complete genome sequence and phylogenetic analysis of hepatitis B virus isolated from Turkish patients with chronic HBV infection.
Bozdayi G; Türkyilmaz AR; Idilman R; Karatayli E; Rota S; Yurdaydin C; Bozdayi AM
J Med Virol; 2005 Aug; 76(4):476-81. PubMed ID: 15977237
[TBL] [Abstract][Full Text] [Related]
29. Evolution of hepatitis B virus precore/basal core promoter gene in HBeAg-positive chronic hepatitis B patients receiving lamivudine therapy.
Lin CL; Liao LY; Wang CS; Chen PJ; Lai MY; Chen DS; Kao JH
Liver Int; 2004 Feb; 24(1):9-15. PubMed ID: 15101995
[TBL] [Abstract][Full Text] [Related]
30. Analysis of the complete hepatitis B virus genome in patients with genotype C chronic hepatitis in relation to HBeAg and anti-HBe.
Zhang K; Imazeki F; Fukai K; Arai M; Kanda T; Mikata R; Yokosuka O
J Med Virol; 2007 Jun; 79(6):683-93. PubMed ID: 17457922
[TBL] [Abstract][Full Text] [Related]
31. [Can HBsAg levels guide to differentiate inactive HBsAg carriers from HBeAg negative chronic B hepatitis?].
Sayan M; Mutlu B; Erdoğan S; Meriç M; Willke A
Mikrobiyol Bul; 2007 Jan; 41(1):87-93. PubMed ID: 17427556
[TBL] [Abstract][Full Text] [Related]
32. Hepatitis B virus genotypes and precore/core-promoter mutations in Tunisian patients with chronic hepatitis B virus infection.
Ayed K; Gorgi Y; Ayed-Jendoubi S; Aouadi H; Sfar I; Najjar T; Ben Abdallah T
J Infect; 2007 Mar; 54(3):291-7. PubMed ID: 16911832
[TBL] [Abstract][Full Text] [Related]
33. Hepatitis B virus reactivation in patients receiving chemotherapy for malignancies: role of precore stop-codon and basic core promoter mutations.
Alexopoulou A; Theodorou M; Dourakis SP; Karayiannis P; Sagkana E; Papanikolopoulos K; Archimandritis AJ
J Viral Hepat; 2006 Sep; 13(9):591-6. PubMed ID: 16907845
[TBL] [Abstract][Full Text] [Related]
34. Low HBV-DNA levels in end-stage renal disease patients with HBeAg-negative chronic hepatitis B.
Moutinho RS; Perez RM; Medina-Pestana JO; Figueiredo MS; Koide S; Alberto FL; Silva AE; Ferraz ML
J Med Virol; 2006 Oct; 78(10):1284-8. PubMed ID: 16927290
[TBL] [Abstract][Full Text] [Related]
35. Association of baseline viral factors with response to lamivudine therapy in chronic hepatitis B patients with high serum alanine aminotransferase levels.
Tseng TC; Liu CJ; Wang CC; Chen PJ; Lai MY; Chen DS; Kao JH
Antivir Ther; 2009; 14(2):203-10. PubMed ID: 19430095
[TBL] [Abstract][Full Text] [Related]
36. [Genetic variation and typing of hepatitis B virus in patients with chronic hepatitis B negative for HBeAg].
Su R; Luo N; Yang Y; Zhuang J; Huang X
Nan Fang Yi Ke Da Xue Xue Bao; 2012 Dec; 32(12):1804-7. PubMed ID: 23268415
[TBL] [Abstract][Full Text] [Related]
37. Association of core promoter mutations with viral breakthrough in chronic hepatitis B patients on long-term lamivudine therapy.
Kazim SN; Chauhan R; Das BC; Sarin SK
J Gastroenterol Hepatol; 2006 Oct; 21(10):1525-32. PubMed ID: 16928212
[TBL] [Abstract][Full Text] [Related]
38. Comparison of genotypes C and D of the hepatitis B virus in Japan: a clinical and molecular biological study.
Duong TN; Horiike N; Michitaka K; Yan C; Mizokami M; Tanaka Y; Jyoko K; Yamamoto K; Miyaoka H; Yamashita Y; Ohno N; Onji M
J Med Virol; 2004 Apr; 72(4):551-7. PubMed ID: 14981757
[TBL] [Abstract][Full Text] [Related]
39. Hepatitis B virus genotypes and G1896A precore mutation in 486 Spanish patients with acute and chronic HBV infection.
Rodriguez-Frias F; Jardi R; Buti M; Schaper M; Hermosilla E; Valdes A; Allende H; Martell M; Esteban R; Guardia J
J Viral Hepat; 2006 May; 13(5):343-50. PubMed ID: 16637866
[TBL] [Abstract][Full Text] [Related]
40. Genetic heterogeneity of the precore and the core promoter region of genotype C hepatitis B virus during lamivudine therapy.
Kuwahara R; Kumashiro R; Murashima S; Ogata K; Tanaka K; Hisamochi A; Hino T; Ide T; Tanaka E; Koga Y; Sata M
J Med Virol; 2004 Jan; 72(1):26-34. PubMed ID: 14635007
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
